학술논문
A systematic review and meta-analysis of the efficacy and safety of Mavacamten therapy in international cohort of 524 patients with hypertrophic cardiomyopathy.
Document Type
Article
Author
Source
Heart Failure Reviews; Mar2024, Vol. 29 Issue 2, p479-496, 18p
Subject
Language
ISSN
13824147
Abstract
Copyright of Heart Failure Reviews is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)